Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Oidda I. Museru"'
Autor:
Angela Barrett, Paige Lewis, Paula M. Castaño, Cynthia Gyamfi-Bannerman, Ormarys Castellanos, Oidda I. Museru, Karen R. Broder, Philip LaRussa, Kathleen Jakob, Maria Cano, Melissa S. Stockwell
Publikováno v:
American Journal of Preventive Medicine. 53:282-289
INTRODUCTION: The feasibility and accuracy of text messaging to monitor events after influenza vaccination throughout pregnancy and the neonatal period has not been studied, but may be important for seasonal and pandemic influenza vaccines and future
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2e45d49c72bf2e9596eeb243dd497f2
https://doi.org/10.1016/j.amepre.2017.03.014
https://doi.org/10.1016/j.amepre.2017.03.014
Autor:
Pedro L. Moro, Janet D. Cragan, Karen R. Broder, Yenlik Zheteyeva, Naomi K. Tepper, Oidda I. Museru, Paige Lewis
Publikováno v:
Vaccine. 34:2349-2353
BACKGROUND: In October 2011, the Advisory Committee on Immunization Practices (ACIP) issued updated recommendations that all pregnant women routinely receive a dose of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccde4bd274dfff8a13816ee7096362c2
https://doi.org/10.1016/j.vaccine.2016.03.049
https://doi.org/10.1016/j.vaccine.2016.03.049
Autor:
Karen R. Broder, Christoph P. Hornik, Oidda I. Museru, Lisa A. Grohskopf, Christopher A. Todd, Charles E. McGee, Emmanuel B. Walter, Lynn Harrington
Publikováno v:
Vaccine. 35(48 Pt)
Antipyretics reduce fever following childhood vaccinations; after inactivated influenza vaccine (IIV) they might ameliorate fever and thereby decrease febrile seizure risk, but also possibly blunt the immune response. We assessed the effect of antipy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffc96c5755a0e3b52ea2ae9aaa9ec4b6
https://pubmed.ncbi.nlm.nih.gov/29056422
https://pubmed.ncbi.nlm.nih.gov/29056422
Autor:
Oidda I. Museru, Jorge Arana, Claudia Vellozzi, Janet Cragan, Yenlik Zheteyeva, Dmitry M. Kissin, Faith Barash, Naomi K. Tepper, Karen R. Broder, Pedro L. Moro, Paige Lewis, Natalia Revzina
Publikováno v:
Obstetrics & Gynecology. 122:1271-1278
OBJECTIVE: To characterize maternal and infant outcomes for pregnant women who received live H1N1 influenza vaccine and had no reported adverse events. METHODS: We identified Vaccine Adverse Event Reporting System reports, which described receipt of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a660226298bee236b80184094720d69
https://doi.org/10.1097/aog.0000000000000010
https://doi.org/10.1097/aog.0000000000000010
Autor:
Manish M. Patel, James Baggs, Xin Yue, Michael Haber, Frank DeStefano, Yi Pan, Oidda I. Museru, Umesh D. Parashar, Penina Haber, Paige Lewis
Publikováno v:
Pediatrics. 131:1042-1049
BACKGROUND: In 2006 and 2008, 2 new rotavirus vaccines (RotaTeq [RV5] and Rotarix [RV1]) were introduced in the United States. METHODS: We assessed intussusception events reported to the Vaccine Adverse Event Reporting System from February 2006 throu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfbebdeb5ad5264cfecdcdfeb7029c75
https://doi.org/10.1542/peds.2012-2554
https://doi.org/10.1542/peds.2012-2554
Autor:
Paige Lewis, Pedro L. Moro, Margaret M. Cortese, A. Patricia Wodi, Oidda I. Museru, Karen R. Broder, Laura L. Polakowski
Publikováno v:
Open Forum Infectious Diseases. 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10c71f308b653babfd6132f9d702e178
https://doi.org/10.1093/ofid/ofw172.657
https://doi.org/10.1093/ofid/ofw172.657
Autor:
Paige Lewis, Oidda I. Museru, Karen R. Broder, Yenlik Zheteyeva, Jing Shi, Pedro L. Moro, Xin Yue
Publikováno v:
Vaccine. 33(4)
Background In 2006, quadrivalent human papillomavirus (HPV4; Gardasil, Merck & Co., Inc.) vaccine was licensed in the US for use in females aged 9–26 years. HPV4 is not recommended during pregnancy; however, inadvertent administration during pregna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d54430eee767293f060ef9edc710a08
https://pubmed.ncbi.nlm.nih.gov/25500173
https://pubmed.ncbi.nlm.nih.gov/25500173
Publikováno v:
American journal of obstetrics and gynecology. 210(6)
Objective To characterize adverse events (AEs) after hepatitis A vaccines (Hep A) and hepatitis A and hepatitis B combination vaccine (Hep AB) in pregnant women reported to the Vaccine Adverse Event Reporting System (VAERS), a spontaneous reporting s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79598c0ff5f2e82fe1baaf114ac78ce0
https://pubmed.ncbi.nlm.nih.gov/24378675
https://pubmed.ncbi.nlm.nih.gov/24378675
Autor:
Tom T. Shimabukuro, Karen R. Broder, Maria Cano, Theresa Harrington, David Menschik, Pedro L. Moro, Oidda I. Museru
Publikováno v:
Vaccine. 31(43)
BACKGROUND: In May 2011, the first trivalent inactivated influenza vaccine exclusively for intradermal administration (TIV-ID) was licensed in the US for adults aged 18–64 years. OBJECTIVE: To characterize adverse events (AEs) after TIV-ID reported
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6813d6184e666aa0e71c0607b18d355
https://pubmed.ncbi.nlm.nih.gov/23994022
https://pubmed.ncbi.nlm.nih.gov/23994022